# US 2006/0078996 A1 · Surface transfection and expression procedure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078996 A1
- Document ID: US20060078996A1
- Status: Published application
- Kind: A1
- Application number: 11/084,411
- Filed: 2005-03-18
- Published: 2006-04-13
- Earliest claimed: 2000-11-03
- Inventors: Michael Uhler
- Web page: https://patentgrep.com/patent/US20060078996A1

## CPC

- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- B01J 2219/00317: Microwell devices, i.e. having large numbers of wells
- B01J 2219/00605: the compounds being directly bound or immobilised to solid supports
- B01J 2219/0061: The surface being organic
- B01J 2219/00612: the surface being inorganic
- B01J 2219/00621: by physical means, e.g. trenches, raised areas
- B01J 2219/00626: Covalent
- B01J 2219/00637: by coating it with another layer
- B01J 2219/00659: Two-dimensional arrays
- B01J 2219/00722: Nucleotides
- B01J 2219/00743: Cells
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B 60/14: for creating libraries
- G01N 2500/10: involving cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method of transfecting cells comprising applying cells directly onto nucleic acids which are immobilized in transfection complexes on a surface and which transfect the cells. Preferably, the nucleic acids are immobilized in an array. In another aspect of the present invention, the method further includes expression of the nucleic acids in the transfected cells. In yet another aspect of the present invention, the method further comprises detecting the expression of the nucleic acids in the transfected cells.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method of transfecting a cell, comprising:
a) providing:
i) a transfection complex immobilized on a surface, said complex comprising at least 2 types of nucleic acid; and
ii) a plurality of cells; and
b) contacting said cells with said at least 2 types of nucleic acids in the transfection complex under conditions such that said cells are co-transfected with said 2 types of nucleic acid.

### Claim 22 (depends on 21)

The method of claim 21, wherein said 2 or more types of nucleic acid comprises 4 or more types of nucleic acid.

### Claim 23 (depends on 21)

The method of claim 21, wherein approximately 100% of cell transfected with one of said 2 types of nucleic acid are transfected with each of said at least 2 types of nucleic acid.

### Claim 24 (depends on 21)

The method of claim 21, wherein at least 50% of cell transfected with one of said 2 types of nucleic acid are transfected with each of said at least 2 types of nucleic acid.

### Claim 25 (depends on 21)

The method of claim 21, wherein said transfection complex further comprises first and second complexing agents.

### Claim 26 (depends on 25)

The method of claim 25, wherein said first complexing agent comprises a ligand for a receptor, and said second complexing agent comprised a DNA binding molecule.

### Claim 27 (depends on 21)

The method of claim 21, wherein the transfection complex further comprises a third complexing agent, said third complexing agent comprising a membrane permeable molecule.

### Claim 28 (depends on 21)

The method of claim 21, wherein the transfection complex further comprises one or more additional complexing agents selected from the group consisting of targeting molecules, transcription molecules, nucleic acid degradation inhibitors, cell growth and integrity modulators, and mixtures thereof.

### Claim 29

A method of transfecting a plurality of cells, comprising:
a) immobilizing a transfection complex on a surface, said transfection complex comprising at least 2 types of nucleic acid;
b) contacting said cells with said immobilized transfection complex under conditions such that said cells are transfected, and wherein approximately 100% of cell transfected with one of said 2 types of nucleic acid are transfected with each of said at least 2 types of nucleic acid.

### Claim 30 (depends on 29)

The method of claim 29, wherein said transfection complex comprises at least 4 types of nucleic acid.

### Claim 31 (depends on 29)

The method of claim 29, wherein said transfection complex further comprises first and second complexing agents, said first complexing agent comprising a ligand for a receptor, said second complexing agent comprising a DNA binding molecule.

### Claim 32 (depends on 29)

The method of claim 29, wherein said transfection complex further comprises a third complexing agent, said third complexing agent comprising a membrane permeable molecule.

### Claim 33

A transfection complex comprising at least two types of nucleic acid and first and second complexing agents.

### Claim 34 (depends on 33)

The transfection complex of claim 33, wherein said first complexing agent comprises a ligand for a receptor and said second complexing agent comprises a DNA binding molecule.

### Claim 35 (depends on 33)

The transfection complex of claim 33, further comprising a third complexing agent, said third complexing agent comprising a membrane permeable molecule.

### Claim 36 (depends on 34)

The transfection complex of claim 34, wherein the DNA-binding molecule is a cationic protein.

### Claim 37 (depends on 35)

The transfection complex of claim 35, wherein the membrane permeable molecule is a cationic lipid.

### Claim 38 (depends on 35)

The transfection complex of claim 35, wherein the ligand is covalently linked to said cationic protein.

### Claim 39 (depends on 33)

The transfection complex of claim 33, further comprising at least one additional complexing agent selected from the group consisting of targeting molecules, transcription molecules, nucleic acid degradation inhibitors, cell growth and integrity modulators, and mixtures thereof.

### Claim 40 (depends on 33)

The transfection complex of claim 33 immobilized to a solid surface.
